Search hospitals > Missouri > Saint Joseph

MediSearch Clinical Trials

Claim this profile
Saint Joseph, Missouri 64506
Global Leader in Atopic Dermatitis
Conducts research for Medical Device Dermatitis
Conducts research for Skin Conditions
Conducts research for Acne
Conducts research for Hidradenitis Suppurativa
57 reported clinical trials
1 medical researcher
Photo of MediSearch Clinical Trials in Saint JosephPhoto of MediSearch Clinical Trials in Saint JosephPhoto of MediSearch Clinical Trials in Saint Joseph

Summary

MediSearch Clinical Trials is a medical facility located in Saint Joseph, Missouri. This center is recognized for care of Atopic Dermatitis, Medical Device Dermatitis, Skin Conditions, Acne, Hidradenitis Suppurativa and other specialties. MediSearch Clinical Trials is involved with conducting 57 clinical trials across 57 conditions. There are 1 research doctors associated with this hospital, such as Melody Stone.

Top PIs

Clinical Trials running at MediSearch Clinical Trials

Atopic Dermatitis
Hidradenitis Suppurativa
Prurigo Nodularis
Acne
Skin Conditions
Dermatitis
Eczema
Vitiligo
Skin Diseases
Hypotrichosis
Image of trial facility.

Upadacitinib

for Eczema

Atopic dermatitis (AD) is a skin condition that may cause a rash and itching due to inflammation of the skin. Therapies spread over the skin may not be enough to control the AD in trial participants who require systemic anti-inflammatory treatment. This study aims to provide data on the efficacy and safety of upadacitinib at different doses in adult participants with moderate to severe AD. Upadacitinib is an approved drug for the treatment of moderate to severe atopic dermatitis (AD). This study is conducted in 2 periods. During Period 1, participants are randomly assigned into 1 of 2 groups called treatment arms to receive upadacitinib 15mg or dupilumab 300mg. Based on the participants response to upadacitinib 15mg, they may have their dose increased to upadacitinib 30mg after 2 weeks. In Period 2, participants that completed Period 1 will either remain on their assigned dose or be reassigned to a different dose based on their Eczema Area and Severity Index (EASI) response. Approximately 200 adult participants ages 18 to less than 64 with moderate to severe AD who are current users of dupilumab and had a history of inadequate response to dupilumab will be enrolled at up to 130 sites worldwide. The study is comprised of a 35-day Screening Period, an 8-week Open-Label Period 1 and a 24-week Open-Label Period 2 for participants that completed Period 1. Participants will receive upadacitinib oral tablets once daily or dupilumab subcutaneous (SC) injection every other week for 32 weeks and followed for 30 days. There may be higher treatment burden for participants in this trial compared to their standard of care. Participants will attend regular visits during the study at a hospital or clinic. The effect of the treatment will be checked by medical assessments, blood tests, checking for side effects and completing questionnaires.
Recruiting2 awards Phase 32 criteria
Image of trial facility.

Ruxolitinib Cream

for Eczema

The purpose of the study is to assess the efficacy and safety of ruxolitinib cream in children and adolescents (6 to \<18 Years Old) with moderate atopic dermatitis.
Recruiting1 award Phase 33 criteria
Image of trial facility.

GHZ339

for Eczema

This trial is designed to evaluate multiple compounds in participants with moderate to severe atopic dermatitis (AD).
Recruiting0 awards Phase 22 criteria

Similar Hospitals nearby

Frequently asked questions

What kind of research happens at MediSearch Clinical Trials?
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Terms of Service·Privacy Policy·Cookies·Security
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Terms of Service·Privacy Policy·Cookies·Security